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Abstract
Background: Digital image (DI) analysis avoids visual subjectivity in interpreting
immunohistochemical stains and provides more reproducible results. An automated
procedure consisting of two variant methods for quantifying the cytokeratin-19
(CK19) marker in breast cancer tissues is presented.
Methods: The first method (A) excludes the holes inside selected CK19 stained areas,
and the second (B) includes them. 93 DIs scanned from complete cylinders of tissue
microarrays were evaluated visually by two pathologists and by the automated
procedures.
Results and conclusions: There was good concordance between the two
automated methods, both of which tended to identify a smaller CK19-positive area
than did the pathologists. The results obtained with method B were more similar to
those of the pathologists; probably because it takes into account the entire positive
tumoural area, including the holes. However, the pathologists overestimated the
positive area of CK19. Further studies are needed to confirm the utility of this
automated procedure in prognostic studies.
Introduction
In the late 1990s, tissue microarray (TMA) technology began to revolutionize the inves-
tigation of potential prognostic and predictive biomarkers [1]. This technology has facili-
tated high-throughput immunophenotypic analysis in a large series of tissues from
different patients on a single glass slide and can serve as a powerful research tool [2].
TMAs can be used to study tissue morphology, protein and gene expression and
chromosomal aberrations using different stains, such as those of immunohistochemis-
try (IHC) and in situ hybridization. The combination of TMAs with clinical samples is
an elegant and cost-effective approach to studying panels of biomarkers under identical
experimental conditions and to developing prognostic or predictive patterns of patient
outcomes [3]. The degree of correlation between TMAs and whole-tissue sections may
not be considered ideal at the diagnostic level for individual patients, but is widely
regarded as adequate for research purposes [4].
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IHC, a cheap and accessible diagnostic technique, is used in daily clinical practice in
pathology departments. This technique is essential for the in situ assessment of protein
expression, complements morphological information with molecular information, and
enables the prediction of responses to targeted therapy [5]. Antibodies used in IHC are
the most frequently used in modern biomedical research and the abundance of IHC stu-
dies over the last 20 years attests to the technique’s popularity [6]. IHC combined with
TMA technology increases the throughput of protein expression analysis in tissues and
improves assay reproducibility [7,8]. However, the strategy generates a large amount of
information that requires painstaking and time-consuming interpretation. The method
most commonly used to evaluate and quantify IHC staining in TMAs is visual microsco-
pical analysis, but it is extremely tedious, prone to error and can outweigh the advan-
tages of the high-throughput TMA format. In addition, human interpretations are
highly subjective because of the difficulty of establishing the staining intensity para-
meters, thereby predisposing the process to inter- and intra-observer variability [9,10].
In recent years, pathology procedures have become significantly more automated.
Slide preparation, staining, scanning and digital image (DI) analysis of samples have all
benefited from such automation. Recent technological advances have made it possible to
acquire and store high-quality DIs [11]. Several platforms are commercially available for
scanning tissue sections and generating DIs of whole slides. Also, several commercial
image analysis applications for IHC quantification are available for some biomarkers and
have received clearance from the US Food and Drug Administration (FDA). Digital
imaging technology allows the interpretation of IHC results to be standardized, avoiding
visual subjectivity and providing more reliable and reproducible results [12,13]. The
combination of image analysis software readily available from the public domain, like
Image J, with the most commonly used IHC staining methods in surgical pathology
practice, is becoming an important approach to diagnostic pathology and research with
regard to prognosis and novel targeted therapies for pathologies of the breast and other
tissues [14].
Many published studies have compared the results from automated procedures and
from visual evaluation of DIs from a small portion of tissue in TMA cylinders [12,15].
Some studies have observed that the variability depends not only on the location of
the stain in the cell [16], but also on the number and distribution of the cells [17].
Nevertheless, the variability due to the evaluation of a whole image of each cylinder of
the TMA in images obtained by digital scanning of TMA has not been thoroughly
investigated. In this study, we present an automated processing procedure with two
variant methods developed in Fiji (Image J) for quantifying the IHC marker cytokera-
tin-19 (CK19) in breast cancer tissues using DIs of TMA cylinders. CK19, the main
cytoskeleton protein of epithelial cells, is highly expressed in tumoural breast cancer
cells [18,19] and is the most common single marker used for detecting disseminated
tumour cells [20]. The results obtained by the two automated methods were compared
with those from the visual quantification of the same DIs by two trained pathologists.
Material and methods
Tissue microarray preparation and immunohistochemistry
93 samples of ductal invasive breast cancer diagnosed between 2000 and 2007 were
selected from the collection of the Tumour Banks of the Pathology Department of the
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Hospital Verge de la Cinta. Two cores of representative tumour area were selected by
an expert pathologist from each paraffin-embedded breast tissue biopsy of the patient.
The 2-mm diameter cores were distributed into ready-made holes in a paraffin block
using the Arraymold tool. The TMAs contained 50 holes.
For IHC, 3 µm-thick sections of TMAs were dried, deparaffinized in xylene, rehy-
drated in graded ethanol, and washed in water and PBS [17]. Each slide was immunos-
tained with the monoclonal antibodies directed against the CK19 antigen (CK19; clone
RCK108, Dako, Carpinteria, CA). The IHC technique was performed by the ENDVI-
SIONTM FLEX (Dako, Carpinteria, CA) method, using the chromogen diaminobenzi-
dine (DAB) as a substrate. Finally, tissues were counterstained with haematoxylin,
dehydrated and mounted according to the manufacturer’s instructions and laboratory
protocol. The entire process was standardised to ensure high reproducibility and stain
homogeneity, since these are very important requirements for image analysis [21] and
also reduce the costs. The study received approval from the scientific and ethical com-
mittee from Hospital Joan XXIII.
Image acquisition
All stained slides were scanned with the Slide Scanner Aperio ScanScope XT at 40X
magnification (20X with 2X magnification changer) to obtain DIs of TMAs. The same
white balance values were used during the scanning of the slides to ensure maximum
reproducibility between the illuminations of the DIs and to minimize any differences
in the automated evaluation of the markers. The final resolution of the captured
images was 0.25 µm/pixel [11]. The correct digitization of each TMA was checked
using ImageScope software. The mean size of each scanned TMA was around 30 GB.
Each cylinder comprising the TMA was then extracted as an individual DI with algo-
rithms developed by the VISILAB group of the University of Castilla-La Mancha,
Spain. Each digital image corresponded to one cylinder and was assigned an individual
identification number. The DIs obtained were saved in uncompressed tagged-image file
(TIFF) format.
Manual quantification
For visual quantification, each DI was opened in Fiji. Two trained pathologists from
the Hospital de Tortosa Verge de la Cinta directly evaluated digital images of each
case on a computer screen, determining the percentage of the total area of the cylinder
that was positively stained with CK19. Before manual evaluation, evaluation criteria
were agreed by the pathologists, since quantification of the percentage of the CK19
positive area had no previously established criteria as part of their daily practice. All
results were exported to a Microsoft Excel 2003 worksheet.
Automated quantification
The automated quantification procedure consisted of two steps, carried out without
previous image calibration: the evaluation of the total area of each cylinder and the
evaluation of the area of each cylinder that was positively stained with CK19. Images
were analysed with Fiji image processing software, which supports a macro language
for specific procedures that allows the sequential reproduction and automation of all
steps a Lab colour model with L channel in range 0-255.
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First step: evaluation of total area of cylinder.
In this step, the total area of each cylinder was calculated as the total number of
pixels inside the cylinder by using the L channel of CIE L*a*b* colour model and
applying a median filter before segmenting the image. First, the digital image was
divided into the three greyscale channels of the model colour CIE L*a*b* and the L
channel was selected for further processing. This channel contained the lightness
image information, allowed better discrimination between the values of the pixels
inside and outside the cylinder based on thresholding. A 3x3 median filter was then
applied to the L channel image, which replaced each pixel inside the cylinder with
the median of neighbouring pixels. This filter reduced noise and homogenised pixel
values inside and outside the cylinder. Finally, the pixels inside the cylinder were
segmented with the threshold tools of Fiji software in order to select those objects
containing pixels with greyscale values from 0 to 238 and with an area larger than
1 million pixels. It was applied in order to select all the pixels that made up the
cylinder. Under these conditions we were able to select a single object representing
the entire cylinder (Figure 1A).
Second step: quantification of CK19-stained area
The second step evaluated the total number of positive brown pixels inside each
cylinder. For this purpose, the original image was split into three single images, one
for each colour channel of the RGB model. Then, an empirical method to establish a
“colour translation” formula to create a “brown channel” was used. The formula,
developed by Ruifrok, generated a greyscale image with the brown channel by apply-
ing the following mathematical operations to the RGB channels: Brown channel =
Blue-0.3*(Red + Green). It is a completely automatic method with no need for inten-
sity or colour calibration, or to know in advance the spectral properties of the pure
dyes that are to be separated [22]. Subsequently, the greyscale image was segmented
using a threshold from 0 to 70 from range 0-255 to select the brown colour pixels
and thereby the tumour area stained by CK19. Finally, after evaluation of different
cut-offs, we selected the objects with an area greater than 1000 pixels in order to
exclude background pixels and artefacts. The sum of all the segmented areas corre-
sponds to the total positive area of CK19 staining (Figure 1B).
Figure 1 Steps in the automated quantification procedure. First step, with the total area of the cylinder
delimited in blue (A). Second step, with the area selected inside the TMA cylinder marked in red (B).
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At the end of the second step, two variant methods (A and B) were employed to deter-
mine the total tumour area stained with CK19. Method A excluded the segmentation
holes inside the positively stained area. These holes are the pixels that correspond to the
light of the tumour glands and the pixels of the nuclei inside the segmented objects. In
method A, the final result was the sum of all positive brown objects, consisting of all pix-
els corresponding to the tumour area stained with CK19. Conversely, method B con-
sisted of the same positive objects as in method A and the pixels of the segmentation
holes inside the positively stained area. The final result of method B was the sum of all
positive brown objects, the nuclei and the light of the tumour glands of these objects.
Calculation of the positively stained CK19 area
All the values corresponding to the total number of pixels in the cylinder and the pix-
els of the stained area inside the cylinder were automatically exported to a Microsoft
Excel 2003 worksheet. The percentages of positively stained CK19 area were taken as
the ratio of the number of brown pixels evaluated in the second step of the procedure
(method A or B) to the total number of pixels in each cylinder, as determined in the
first step of the procedure.
Statistical analysis
All statistical analyses were done using SPSS version 21.0 (SPSS Inc., IBM). The intra-
class correlation coefficient (ICC), Bland-Altman and Kaplan-Meier analyses, with their
corresponding graphical output, were used to evaluate the agreement between the
results of the pathologists’ observations (inter-observer) and between the results of
each pathologist with each automated method. The results of the two automated meth-
ods (inter-method) were compared solely with the Bland-Altman graphs.
The Bland-Altman analysis assumes that neither system is a gold standard but merely
compares two methods or procedures. The conditional probabilities of observing a dif-
ference between paired measurements were estimated by the Kaplan-Meier procedure.
The ICC is a measure of the reliability of measurements or ratings, for the purpose of
assessing inter-rater reliability. In this study we calculated the ICC of absolute agree-
ment, which included the variability due to the observers. The ICC was calculated from
a two-way random-effects analysis of variance with an index of agreement ranging from
0 (no agreement) to 1 (perfect agreement). The following ICC interpretation scale was
used as poor (below 0.40), acceptable (0.40-0.74) and excellent (0.75-1) [23].
Results
Inter-observer comparisons
Figure 2A illustrates the results of the Bland-Altman analysis, showing the spread of
the values around the mean difference between the two observers. These differences
were not homogeneous, since observer 1 tended to discern a larger positive area per-
centage than did observer 2. However, the spread of the differences around the mean
difference between the two observers was more or less constant in all digital images
and did not appear to be influenced by the complexity of the images (low or high per-
centages of brown positive objects). These differences ranged from -20% to 10% and
65% of the results had differences of less than 5%. The ICC indicated an excellent level
of agreement between the two observers (0.823; 95% CI: 0.631 - 0.905).
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Inter-method comparisons
Figure 2B illustrates the results of the Bland-Altman analysis, showing the spread of
the values around the mean difference between the two methods. This demonstrates
the close agreement between the two automated methods excluding (method A) or
including (method B) the segmentation holes inside the positively stained area, as
explained above. The differences between methods A and B were closer to zero when
the positive area was less than 10% of the whole; when the percentage positive area
was less than 55% the differences between the two methods were less than 10%. On
the other hand, when the cylinder area was more than 55% positive, we found differ-
ences of 10% to 30% between the two automated methods.
Comparison between the manual and automated methods
Figures 3A and 3B respectively show the superimposed Bland-Altman graphs compar-
ing the results obtained by observers 1 and 2 with those from the two automated
methods. The two observers tended to estimate a larger positive area than was calcu-
lated by the automated methods. However, observer 1’s results showed greater discre-
pancies with the automated methods than those of observer 2. The differences
Figure 2 Overall results obtained by manual and automated evaluation. Bland-Altman graphs reveal
the differences between the two observers (A) and between the two automated methods (B).
Figure 3 Superimposed Bland-Altman graphs. The curves showed the differences between the observer
1 and the two automated methods (A) and between observer 2 and the automated methods (B). Black
and grey dots indicate methods A and B, respectively.
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between the visual and automated methods were more pronounced for method A
(holes excluded) than for method B (holes included). The results obtained by observer
2 showed an acceptable level of agreement with those obtained by method A (ICC =
0.663; 95% CI: 0.00 - 0.882) and excellent agreement with those obtained by method B
(ICC = 0.772; 95% CI: 0.209 - 0.909). Observer 1’s results showed an acceptable level
of agreement with those obtained by the method B (ICC = 0.563; 95% CI: 0.001 -
0.794). The ICC between the results of observer 1 and of method A was not an appro-
priate measure because the condition of equality of variances was not satisfied.
The conditional probabilities of observing differences between the measurements
were estimated by the Kaplan-Meier procedure (Figure 4). Comparison of the Kaplan-
Meier curves confirmed the differences between the two observers and between the
observers and the two automated methods. The curves indicated that differences were
less likely to arise when comparing the two pathologist’s counts. The use of method B
produced the smallest differences between the results of the automated procedure and
those obtained by the two pathologists.
Discussion
TMAs facilitate high-performance immunohistochemistry, but their analysis presents a
number of problems when done manually by optical microscopy. As for single biopsy,
the time required, the subjectivity arising from the heterogeneity of staining intensities,
and the size, shape and distribution of the cells are major disadvantages of manual eva-
luation that can be resolved through the use of automated DI analytical procedures.
The automated analysis of immunohistochemically stained cells in DIs of complete
Figure 4 Superimposed Kaplan-Meier graphs. The curves compared the probability of difference
between the two observers (black line), observer 2 and automated methods A (solid red line) and B
(dashed red line), and observer 1 and the automated methods A (solid blue line) and B (dashed blue line).
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cylinders extracted from TMAs have been little studied [3,9,24]. Here, we present two
automated methods that allow us to measure the percentage of the total area of each
cylinder of the TMA that is positively immunohistochemically stained by CK19. We
compared these results with the quantifications of two trained pathologists who viewed
the same DIs on the computer screen.
The ICC coefficient indicated excellent agreement between the two observers. Never-
theless, the range of differences (-20% to 10%) in the results of the two observers sug-
gested the existence of some inter-observer variability in the evaluation of DIs. Besides
the subjectivity of the visual determination of positivity arising from the interpretation
of DAB intensity [16], the differences between the observers did not appear to be influ-
enced by the percentage of positive area of CK19. So, to the human eye, the evaluation
of the percentage positive area in a large image corresponding to an entire cylinder is
not influenced on the cell concentrations. On the contrary, it has been observed that
the percentage or the number of positive cells in small images, influence in the varia-
bility of human eye evaluation. The difficulties in evaluating the whole area are prob-
ably greater because the human eye discerns as positive not only the stained area but
also some of the regions within it.
We found a good concordance between the results from automated methods A and
B only when the positive area of the cylinders was less than 10%. The larger differences
observed when the percentage of positive area in the cylinders was greater than 55%
were probably because the number of “tumoural glands” in these DIs is more impor-
tant. Exclusion (method A) or inclusion (method B) of the pixels corresponding to the
light of the tumour glands and the pixels of the nuclei inside the segmented objects,
could explain the differences observed in our study. On the other hand, our results
also showed that these automated methods tended to identify a smaller positive area
than the two manual evaluations. It may be due to the difficulty the human eye has in
determining the percentage positive area in large images with a large amount of brown
stain without using tools. When manual and automated evaluations of whole slide
images of breast tissue stained only with haematoxylin-eosin (without DAB staining)
were compared, the two methods proved to have similar accuracy, precision and repro-
ducibility [11]. For both observers, the differences were more pronounced with method
A (holes excluded) than with method B (holes included). This may be because the lat-
ter method more closely mimics the process of manual quantification. The pathologists
interpreted the total positive tumoural area as the area stained with brown colour, the
nuclei included in them and also the light of all the tumoural glands. Then, they inter-
preted the total positive tumoural area, automatically including the total positive
tumoural area, rather than solely the brown pixels. However, even when these areas
were included in the automated method the pathologists still overestimated the posi-
tive area.
Other comparative studies of manual and automated IHC evaluations have already
been published [16,25-28]. The pattern of staining of the markers evaluated, the type
and size of the DIs analysed, and the manner of portraying the results (e.g., frequency
of positive cells, percentage of positive area, and threshold levels of positivity or cut-off
values) may explain some of the discrepancies between the manual and automated
results obtained in these studies. A relatively good correlation has been found in a
study of prostate cancer specimens when the percentage of positively stained areas in a
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TMA cylinder evaluated by image analysis software was compared to the manual quan-
tification [15]. However, in that study the percentage of stained epithelial cells was
reduced to categorical scores (1, <33%; 2 33%-66%; 3, >66%), which simplified the
manual evaluation and thereby considerably reduced the differences that may arise
between manual and automated methods.
Conclusion
As compared to manual evaluation, automated image analysis is a simple and econom-
ical method of quantifying and scoring immunohistochemically stained markers that
improve the levels of sensitivity, precision, reproducibility and standardization of these
kinds of measurements. Moreover the advances in automated evaluation of immuno-
histochemical markers in whole-slide digital images offer a practical means of improv-
ing the accuracy and reproducibility of these measurements for diagnosis, education
and research purposes. The analysis of complete TMA cylinders provides more infor-
mation about the prognostic biomarkers in a single image and avoids the loss of infor-
mation needed to detect prognostic biomarkers. This study is the first part of a project
that aims to compare the quantity of different immune response markers in relation to
the percentage of the tumoural area (CK19) for the purpose of developing a prognostic
factor. Further work is needed to evaluate which of these methods (automated meth-
ods A or B versus manual evaluation) will be the best one to use in future prognostic
studies.




FDA: Food and Drug Administration
CK19: Cytokeratin-19
TIFF: Tagged image file format
DAB: Diaminobenzidine
ICC: Intraclass correlation coefficient
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